Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 1.99M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -78.01M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -46.00% |
| Sales | 16.84M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -87.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | 73.50% | 52W High Chg | -99.00% |
| Recommedations | 2.00 | Quick Ratio | 0.04 | Shares Outstanding | 1.99M | 52W Low Chg | 18.00% |
| Insider Own | - | ROA | -155.38% | Shares Float | 1.73M | Beta | -1.19 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | 69.46K/142.57K | Price | 1.00 |
| Gross Margin | 73.78% | Profit Margin | - | Avg. Volume | 35,067 | Target Price | 225.00 |
| Oper. Margin | -499.64% | Earnings Date | Aug 2 | Volume | 51,800 | Change | 0.00% |
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.